Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-03-15-Speech-4-113"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010315.5.4-113"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
In the Purvis report, the Committee on Industry, External Trade, Research and Energy asks the European Parliament to support the major private companies in the biotechnology sector and to promote their individual interests. It demands that Member States encourage private industry to penetrate further into universities and public institutions. It calls upon researchers to participate in setting up private businesses. It wants more mobility between universities and the private sector. It welcomes the progress achieved in the financial markets and is in favour of stock options. It invites businesses to play an active role in ‘informing’ the public about GMOs – as if we were not already subjected to massive ideological publicity campaigns from these industrial groups!
The resolution tabled by the Committee on Industry leads the way in favour of GMO production. It claims that there is no objective scientific opinion on which to base their non-authorisation. It calls for the immediate lifting of the ‘effective moratorium’ that is holding back the marketing of these products. It wants field trials to be authorised, even though this would mean the inevitable uncontrolled spread of GMOs. A few considerations on the need to draw up ‘ethical guidelines’ do nothing to hide the essential nature of this resolution, i.e. to oppose all the public movements that are currently campaigning on this issue."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples